)
2cureX (2CUREX) investor relations material
2cureX H2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Continued execution under a clarified group structure, focusing on commercial access and patient engagement in precision oncology.
Strategic partnership with 2cureX A/S for development and regulatory approval of IndiTreat; commercial model aligned for hospital installations in 2026.
Entered a non-binding LOI with PreComb Therapeutics AG for potential collaboration in precision oncology.
First direct-to-patient IndiTreat test conducted, marking a milestone in patient engagement.
Proceeds from the sale of 2cureX A/S (MSEK 5.6) partially distributed to shareholders, with the remainder pending annual report review.
Financial highlights
Net sales for H2 2025 were 0 KSEK; other operating income was 3 KSEK.
Operating profit for H2 2025 was -644 KSEK; profit before tax was -659 KSEK.
Cash and bank balances stood at 2,096 KSEK as of December 31, 2025.
Equity ratio as of December 31, 2025 was -1.7%.
Earnings per share for H2 2025 was -0.03 SEK.
Outlook and guidance
Focus on refining and executing the commercial access model and supporting patient engagement aligned with hospital-based IndiTreat deployment.
Continued strict capital discipline and close collaboration with strategic partners.
Further updates to be provided as progress continues.
- Leadership changes and a new direct-to-patient strategy follow the sale of key assets.2CUREX
Investor Update20 Jan 2026 - Direct-to-patient model validated, financials improved, and expansion accelerates in H1 2025.2CUREX
H1 202521 Aug 2025 - Restructuring and new financing position 2cureX for a direct-to-patient oncology strategy.2CUREX
H1 202413 Jun 2025 - Major restructuring and new strategy aim to revive growth after a year of losses.2CUREX
H2 20245 Jun 2025
Next 2cureX earnings date
Next 2cureX earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)